These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3398379)

  • 1. [Changes in ASP (antigroup-A streptococcal C polysaccharide antibody) and cardiac and renal effects in cases of urogenital cancers during OK-432 immunotherapy, streptococcus preparation].
    Tanji S; Koike H; Kumagai K; Fujioka T; Kubo T; Ohhori T; Yoshida I
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):49-57. PubMed ID: 3398379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
    Fujioka T; Tanji S; Koike H; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jan; 78(1):29-38. PubMed ID: 3599595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
    Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic relationship between streptococcal preparation OK-432 and tumors and its effect on immunotherapy with OK-432 in patients with superficial bladder tumor.
    Fujioka T; Aoki H; Yoshida M; Ohhori T; Kubo T
    Urol Int; 1989; 44(4):198-204. PubMed ID: 2477930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Su-polysaccharide skin test in lung cancer].
    Harada J; Horiguchi T; Oki K; Miyamoto H; Osada T
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2697-702. PubMed ID: 3307634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
    Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
    Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
    Fujioka T; Shiraishi M; Tanji S; Koike H; Suzuki K; Kumagai K; Aoki H; Sakuma Y; Ohhori T; Kubo T
    Hinyokika Kiyo; 1989 Feb; 35(2):253-7. PubMed ID: 2735236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group.
    Noda K; Teshima K; Tekeuti K; Hasegawa K; Inoue K; Yamashita K; Sawaragi I; Nakajima T; Takashima E; Ikeuchi M
    Gynecol Oncol; 1989 Dec; 35(3):367-72. PubMed ID: 2689304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of streptococcal preparation (picibanil) on the postoperative rise in serum alanine aminotransferase activity in patients with urogenital cancer.
    Taketa K; Ohmori H; Matsumura Y; Asahi T; Okimune M
    Acta Med Okayama; 1980 Dec; 34(6):401-8. PubMed ID: 6451146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of terminal-stage malignant tumors with the immunopotentiator OK-432--a comparison between SU-PS test-responder and -nonresponder patients].
    Yagi Y; Yagi S; Ichiki H
    Gan No Rinsho; 1987 Jun; 33(7):815-21. PubMed ID: 3302349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery.
    Fukuma K; Matsuura K; Shibata S; Nakahara K; Fujisaki S; Maeyama M
    Acta Obstet Gynecol Scand; 1986; 65(2):133-7. PubMed ID: 3727940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group.
    Cancer; 1987 Nov; 60(10):2394-402. PubMed ID: 2889522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune responses and clinical effects of OK-432 immunotherapy in lung neoplasms].
    Watanabe H; Komori Y; Yamada T; Iwa T
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):451-8. PubMed ID: 469305
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-specific immunotherapy with OK-432, streptococcus pyogenes preparation, for inoperable cancer patients of the digestive tract].
    Hanaue H; Nomoto S; Yoshizaki S; Kitano Y; Miyakawa S; Horie F; Kurosawa T; Nemoto A; Yasuda H; Takada T
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1307-14. PubMed ID: 6512346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunotherapy for lung cancer by streptococcal preparation OK-432].
    Watanabe Y; Shimizu J; Yoshida Y; Hashizume Y; Yamada T; Iwa T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1432-5. PubMed ID: 2586434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to OK-432 (picibanil) in cancer patients and change of immunological parameters for the administration of OK-432 (picibanil)].
    Kato K
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Feb; 91(2):215-24. PubMed ID: 3373373
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
    Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
    Watanabe Y; Iwa T
    J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on specific active immunotherapy using immune responses of irradiated tumor tissue. 4. Effects of a combined use of a non-specific immunopotentiator, OK-432].
    Imanaka K; Ogawa Y; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1299-304. PubMed ID: 7153621
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of adjunctive immunotherapy in superficial bladder cancer.
    Fujita K
    Cancer; 1987 Jun; 59(12):2027-30. PubMed ID: 3567865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.